| Literature DB >> 16491083 |
Bernhard J Hering1, Martin Wijkstrom, Melanie L Graham, Maria Hårdstedt, Tor C Aasheim, Tun Jie, Jeffrey D Ansite, Masahiko Nakano, Jane Cheng, Wei Li, Kathleen Moran, Uwe Christians, Colleen Finnegan, Charles D Mills, David E Sutherland, Pratima Bansal-Pakala, Michael P Murtaugh, Nicole Kirchhof, Henk-Jan Schuurman.
Abstract
Cell-based diabetes therapy requires an abundant cell source. Here, we report reversal of diabetes for more than 100 d in cynomolgus macaques after intraportal transplantation of cultured islets from genetically unmodified pigs without Gal-specific antibody manipulation. Immunotherapy with CD25-specific and CD154-specific monoclonal antibodies, FTY720 (or tacrolimus), everolimus and leflunomide suppressed indirect activation of T cells, elicitation of non-Gal pig-specific IgG antibody, intragraft expression of proinflammatory cytokines and invasion of infiltrating mononuclear cells into islets.Entities:
Mesh:
Year: 2006 PMID: 16491083 DOI: 10.1038/nm1369
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 53.440